On 5 March, Dexcom announced the US Food and Drug Administration had granted clearance to its Stelo blood glucose monitor, the first of its kind that will be sold over the counter.
Now, American type II diabetes patients who are not on insulin therapy will be able to easily access top-spec CGM...